American Thoracic Society - Sanofi Investor Call slide image

American Thoracic Society - Sanofi Investor Call

LS mean change (L) ± 95% CI Change in Pre-BD FVC and Pre-BD FEF 25-75% Over Time Pre-BD FVC Pre-BD FEF 25-75% 0.20- 0.18- 0.32- Placebo 0.28- Dupilumab 0.24- 0.20- 0.16- 0.12- 0.08- 0.04- 0.00 -0.04- -0.08 LS mean change (L/sec) ± 95% CI 0.16 0.14- 0.12- 0.10 0.08 0.06 0.04 0.02 T T 0 24 8 12 24 36 44 52 Week No. of participants with observed change from baseline Placebo 471455459439439 Dupilumab 467457454446449 ATS 2023 435 443 024 8 12 24 36 36 Week Placebo Dupilumab 44 52 415 404 420 471455459439 439 435 417 404 420 415 410 426 467457454446 449 443 415 410 426 24 27
View entire presentation